Depression is a serious illness that profoundly affects the thoughts, feelings and actions of those affected, copyright: Karin Kaiser / MHH.
Depression is a serious illness that profoundly affects the thoughts, feelings and actions of those affected , copyright: Karin Kaiser / MHH. MHH psychiatry coordinates largest German study to improve depression treatment Using biomarkers to find individual diagnostic and therapeutic paths - what already works in oncology is also to become possible in psychiatry. Under the leadership of Professor Dr Helge Frieling, Vice Head of the Department of Psychiatry, Social Psychiatry and Psychotherapy at the Hannover Medical School (MHH), a national research network is now being launched that aims to tailor the treatment of depression more closely to the individual patient than before. The project, entitled "Personalised, Predictive, Precise and Preventive Medicine to Improve Early Detection, Diagnosis, Therapy and Prevention of Depressive Disorders" (P4D), aims to develop individualised treatment approaches using biomarkers, but also magnetic resonance imaging, brain wave measurements and sleep diagnostics. While patients with depression have so far all been treated according to the same regimen, P4D aims to determine exactly which therapy is the right one for whom. Seven universities (MHH, Leibniz Universität Hannover, TU Braunschweig, University of Greifswald, University of Würzburg, University of Kiel, University of Frankfurt), the Fraunhofer Institute for Toxicology and Experimental Medicine, the Stiftung Deutsche Depressionshilfe (German Depression Aid Foundation) and the Bavarian company BioVariance are involved in the study, which is funded by the Federal Ministry of Education and Research (BMBF) with ten million euros over five years.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
